Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Perrigo Company plc
PRGO
$13.56
Name : Perrigo Company plc
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $1,866,181,760.00
EPSttm : -0.21
finviz dynamic chart for PRGO
Perrigo Company plc
$13.56
1.60%
$0.22

Float Short %

7.4

Margin Of Safety %

96

Put/Call OI Ratio

0.26

EPS Next Q Diff

-0.15

EPS Last/This Y

4.02

EPS This/Next Y

0.15

Price

13.56

Target Price

19.33

Analyst Recom

2.2

Performance Q

-42.54

Relative Volume

1.44

Beta

0.43

Ticker: PRGO




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-10-20PRGO21.70.390.6825267
2025-10-21PRGO21.930.390.0925400
2025-10-22PRGO21.650.3911.6225536
2025-10-23PRGO21.490.4012.5925757
2025-10-24PRGO21.470.420.0526175
2025-10-27PRGO21.940.421.0126232
2025-10-28PRGO21.60.422.3326344
2025-10-29PRGO21.30.433.4326438
2025-10-30PRGO20.650.442.0826673
2025-10-31PRGO20.730.460.1627080
2025-11-03PRGO20.540.451.3827184
2025-11-04PRGO20.180.461.9627262
2025-11-05PRGO15.10.470.3927488
2025-11-06PRGO14.930.210.9323634
2025-11-07PRGO14.440.212.3024948
2025-11-10PRGO14.240.250.0625913
2025-11-11PRGO14.290.240.5526755
2025-11-12PRGO14.150.240.5927082
2025-11-13PRGO13.980.250.5229127
2025-11-14PRGO13.780.251.4029374
2025-11-17PRGO13.560.260.3129557
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-10-20PRGO21.70-4.667.92.99
2025-10-21PRGO21.92-4.668.92.99
2025-10-22PRGO21.65-4.665.12.99
2025-10-23PRGO21.49-4.666.02.99
2025-10-24PRGO21.47-4.667.02.99
2025-10-27PRGO21.94-4.671.02.99
2025-10-28PRGO21.60-4.664.62.99
2025-10-29PRGO21.29-4.664.82.99
2025-10-30PRGO20.64-4.962.22.98
2025-10-31PRGO20.74-4.968.02.98
2025-11-03PRGO20.55-4.965.72.98
2025-11-04PRGO20.18-4.964.52.98
2025-11-05PRGO15.10-4.925.82.98
2025-11-06PRGO14.93-4.964.62.98
2025-11-07PRGO14.44-11.879.32.80
2025-11-10PRGO14.25-13.622.42.80
2025-11-11PRGO14.30-13.624.22.77
2025-11-12PRGO14.16-13.622.82.77
2025-11-13PRGO13.98-13.622.42.77
2025-11-14PRGO13.77-13.622.32.77
2025-11-17PRGO13.56-13.622.22.77
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-10-20PRGO2.853.476.35
2025-10-21PRGO2.853.476.35
2025-10-22PRGO2.853.476.35
2025-10-23PRGO2.853.476.35
2025-10-24PRGO2.853.476.35
2025-10-27PRGO2.853.518.39
2025-10-28PRGO2.853.518.39
2025-10-29PRGO2.853.518.39
2025-10-30PRGO2.853.518.39
2025-10-31PRGO2.853.518.39
2025-11-03PRGO2.853.568.39
2025-11-04PRGO2.853.568.39
2025-11-05PRGO2.853.568.39
2025-11-06PRGO2.853.568.39
2025-11-07PRGO2.853.568.39
2025-11-10PRGO2.854.328.39
2025-11-11PRGO2.914.328.39
2025-11-12PRGO2.914.327.40
2025-11-13PRGO2.914.327.40
2025-11-14PRGO4.104.327.40
2025-11-17PRGO3.548.767.40
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.8

Avg. EPS Est. Current Quarter

0.8

Avg. EPS Est. Next Quarter

0.65

Insider Transactions

3.54

Institutional Transactions

8.76

Beta

0.43

Average Sales Estimate Current Quarter

1101

Average Sales Estimate Next Quarter

1060

Fair Value

26.6

Quality Score

50

Growth Score

40

Sentiment Score

16

Actual DrawDown %

73.4

Max Drawdown 5-Year %

-72.4

Target Price

19.33

P/E

Forward P/E

4.64

PEG

P/S

0.44

P/B

0.42

P/Free Cash Flow

6.88

EPS

-0.38

Average EPS Est. Cur. Y​

2.77

EPS Next Y. (Est.)

2.92

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1.21

Relative Volume

1.44

Return on Equity vs Sector %

-28.1

Return on Equity vs Industry %

-8.4

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.22

EBIT Estimation

22.2
Perrigo Company plc
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 8379
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
stock quote shares PRGO – Perrigo Company plc Stock Price stock today
news today PRGO – Perrigo Company plc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRGO – Perrigo Company plc yahoo finance google finance
stock history PRGO – Perrigo Company plc invest stock market
stock prices PRGO premarket after hours
ticker PRGO fair value insiders trading